• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性乳腺癌组织学分型的临床影响。

Clinical impacts of histological subtyping primary breast cancer.

机构信息

Institute of Digital Medicine, Stuttgart, Germany.

出版信息

Anticancer Res. 2010 Dec;30(12):5137-44.

PMID:21187502
Abstract

BACKGROUND

Treatment decisions in breast cancer depend on TNM classification and the assessment of additional variables with have an impact on survival. We examined whether histological subtyping breast cancer as either ductal or lobular is related to disease outcome.

PATIENTS AND METHODS

We examined a large data base of 14198 breast cancer patients.

RESULTS

Histological sub-classification of invasive breast cancer as either ductal or lobular is not correlated with disease outcome. However, the data further showed that invasive lobular carcinomas have a higher probability of being oestrogen receptor (ER)- and progesterone receptor (PR)-positive and a lower probability of being c-erbB2-positive. They also showed a higher average age at the time of diagnosis in comparison with invasive ductal carcinoma. Local recurrence rates were lower in invasive lobular carcinoma in comparison with invasive ductal carcinoma (3.5% vs. 6.2%; p = 0.031). The multivariable Cox regression analysis showed that ER, PR, nodal status, grade and tumour size predicted disease outcome with statistical significance, while the histological subtype (invasive ductal or lobular) was not a significant predictor of disease outcome.

CONCLUSION

Histological sub-classification of invasive breast cancer as either ductal or lobular is not correlated with disease outcome. On the other hand our data gives some indication that lobular and ductal breast cancer appear to be different biological entities.

摘要

背景

乳腺癌的治疗决策取决于 TNM 分类以及对生存有影响的其他变量的评估。我们研究了乳腺癌的组织学亚型(导管或小叶)是否与疾病结局相关。

患者和方法

我们检查了 14198 例乳腺癌患者的大型数据库。

结果

浸润性乳腺癌的组织学亚分类为导管或小叶与疾病结局无关。然而,数据进一步表明,浸润性小叶癌更有可能是雌激素受体(ER)和孕激素受体(PR)阳性,而 c-erbB2 阳性的可能性较低。与浸润性导管癌相比,它们在诊断时的平均年龄也更高。与浸润性导管癌相比,浸润性小叶癌的局部复发率较低(3.5%比 6.2%;p=0.031)。多变量 Cox 回归分析显示,ER、PR、淋巴结状态、分级和肿瘤大小与疾病结局具有统计学意义,而组织学亚型(浸润性导管或小叶)不是疾病结局的显著预测因素。

结论

浸润性乳腺癌的组织学亚分类为导管或小叶与疾病结局无关。另一方面,我们的数据表明,小叶癌和导管癌似乎是不同的生物学实体。

相似文献

1
Clinical impacts of histological subtyping primary breast cancer.原发性乳腺癌组织学分型的临床影响。
Anticancer Res. 2010 Dec;30(12):5137-44.
2
Triple-negative breast cancers: unique clinical presentations and outcomes.三阴性乳腺癌:独特的临床表现和结局。
Ann Surg Oncol. 2010 Oct;17 Suppl 3:384-90. doi: 10.1245/s10434-010-1260-4. Epub 2010 Sep 19.
3
[Comparison of clinicopathologic characteristics and prognosis of triple-negative with Her-2-overexpressing breast cancer].三阴性乳腺癌与Her-2过表达乳腺癌的临床病理特征及预后比较
Zhonghua Zhong Liu Za Zhi. 2009 May;31(5):346-50.
4
[Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].[乳腺癌中类固醇激素(雌激素受体、孕激素受体)的免疫组织化学研究]
Georgian Med News. 2005 Feb(119):65-7.
5
Immunohistochemically defined subtypes and outcome of apocrine breast cancer.免疫组织化学定义的大汗腺癌亚型和预后。
Clin Breast Cancer. 2013 Apr;13(2):95-102. doi: 10.1016/j.clbc.2012.11.004. Epub 2012 Dec 14.
6
Implication of laminin and collagen type IV expression in the progression of breast carcinoma.层粘连蛋白和IV型胶原蛋白表达在乳腺癌进展中的意义。
Anticancer Res. 2001 Mar-Apr;21(2B):1395-9.
7
Relationship between oral contraceptive therapy and estrogen receptor status in patients with breast cancer.乳腺癌患者口服避孕药治疗与雌激素受体状态之间的关系。
Anticancer Res. 2008 Jan-Feb;28(1B):491-3.
8
Integrin expression and survival in human breast cancer.整合素在人类乳腺癌中的表达与生存情况
Eur J Surg Oncol. 2004 Jun;30(5):484-9. doi: 10.1016/j.ejso.2004.01.016.
9
Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.ghrelin 的表达与浸润性乳腺癌的良好预后相关。
Acta Oncol. 2012 Mar;51(3):386-93. doi: 10.3109/0284186X.2011.631576. Epub 2011 Nov 9.
10
Primary breast cancer phenotypes associated with propensity for central nervous system metastases.与中枢神经系统转移倾向相关的原发性乳腺癌表型。
Cancer. 2006 Aug 15;107(4):696-704. doi: 10.1002/cncr.22041.

引用本文的文献

1
Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities.对他莫昔芬耐药浸润性小叶乳腺癌细胞的综合分子分析鉴定出 MAPK 和 GRM/mGluR 信号为治疗靶点。
Mol Cell Endocrinol. 2018 Aug 15;471:105-117. doi: 10.1016/j.mce.2017.09.024. Epub 2017 Sep 19.
2
Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation.外泌体介导的微小RNA转移在乳腺癌化疗耐药调控中的作用
Am J Cancer Res. 2016 Oct 1;6(10):2129-2139. eCollection 2016.
3
A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population.
韩国人群中根据分子亚型对乳腺浸润性小叶癌和浸润性导管癌患者临床结局的比较。
World J Surg Oncol. 2014 Mar 13;12:56. doi: 10.1186/1477-7819-12-56.
4
Digital microscopy assessment of angiogenesis in different breast cancer compartments.不同乳腺癌部位血管生成的数字显微镜评估。
Biomed Res Int. 2013;2013:286902. doi: 10.1155/2013/286902. Epub 2013 Sep 1.